BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1715297)

  • 41. Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy.
    Brazzelli V; Prestinari F; Barbagallo T; Vassallo C; Agozzino M; Borroni G
    Eur J Dermatol; 2006; 16(1):59-61. PubMed ID: 16436344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facial tolerability of topical retinoid therapy.
    Leyden J; Grove G; Zerweck C
    J Drugs Dermatol; 2004; 3(6):641-51. PubMed ID: 15624747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro.
    Zouboulis CC; Korge B; Akamatsu H; Xia LQ; Schiller S; Gollnick H; Orfanos CE
    J Invest Dermatol; 1991 May; 96(5):792-7. PubMed ID: 1708801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of combination therapy with tacalcitol lotion associated with sunscreen for localized Darier's disease.
    Abe M; Yasuda M; Yokoyama Y; Ishikawa O
    J Dermatol; 2010 Aug; 37(8):718-21. PubMed ID: 20649714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevation of serum triglyceride levels from oral isotretinoin in disorders of keratinization.
    Katz RA; Jorgensen H; Nigra TP
    Arch Dermatol; 1980 Dec; 116(12):1369-72. PubMed ID: 6161583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of etretinate (Ro 10-9359) on Darier's Disease.
    Löwhagen GB; Michaëlsson G; Mobacken H; Pettersson U; Vahlquist A
    Dermatologica; 1982 Aug; 165(2):123-30. PubMed ID: 7141063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of Darier disease with oral alitretinoin.
    Letulé V; Herzinger T; Ruzicka T; Molin S
    Clin Exp Dermatol; 2013 Jul; 38(5):523-5. PubMed ID: 23777494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy and risks of topical 5-fluorouracil in Darier's disease].
    Le Bidre E; Delage M; Celerier P; De Muret A; Lorette G
    Ann Dermatol Venereol; 2010; 137(6-7):455-9. PubMed ID: 20620575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
    Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
    Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Darier's disease. Treatment with topical vitamin A acid.
    Fulton JE; Gross PR; Cornelius CE; Kligman AM
    Arch Dermatol; 1968 Oct; 98(4):396-9. PubMed ID: 5676695
    [No Abstract]   [Full Text] [Related]  

  • 52. Cantharidin-induced acantholysis in Darier's disease: does acantholysis initiate dyskeratosis?
    Yell JA; Burge SM; Dean D
    Br J Dermatol; 1994 Jul; 131(1):40-7. PubMed ID: 7519031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of a new oral retinoid RO10 9359 in the treatment of Darier's disease.
    Watson AB
    Australas J Dermatol; 1980 Aug; 21(2):76-8. PubMed ID: 7447813
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease.
    Zamiri M; Munro CS
    Br J Dermatol; 2013 Sep; 169(3):709-10. PubMed ID: 23551220
    [No Abstract]   [Full Text] [Related]  

  • 55. [Scabies triggering Darier's disease].
    Drewniok C; Schön MP; Krause M; Gollnick H
    J Dtsch Dermatol Ges; 2003 Sep; 1(9):722-4. PubMed ID: 16285280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of Darier's disease: an update.
    Barron L; Burkhart CG
    Int J Dermatol; 1987 Jun; 26(5):334. PubMed ID: 3475264
    [No Abstract]   [Full Text] [Related]  

  • 57. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients.
    Bulengo-Ransby SM; Griffiths CE; Kimbrough-Green CK; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
    N Engl J Med; 1993 May; 328(20):1438-43. PubMed ID: 8479462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acral Hemorrhagic Darier's Disease: A Case Report.
    Vender R; Vender R
    J Cutan Med Surg; 2016 Sep; 20(5):478-80. PubMed ID: 26992421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Darier's disease with photodynamic therapy.
    Exadaktylou D; Kurwa HA; Calonje E; Barlow RJ
    Br J Dermatol; 2003 Sep; 149(3):606-10. PubMed ID: 14510996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
    Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
    Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.